(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THERAVIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

THERAVIA

ST13

US500000079375788

Class

5, 35

Filing

79375788

Registration

7567588

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

12/19/2025

Classification

Registered

Trademark type

Word

Nice classes

5, 35

Filing date

05/16/2023

Registration date

11/19/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/19/2024

Last transaction

12/19/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

FR

Examiner

EVANKO,PATRICIA MALESARDI

Law office

N10

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

T. P. (pessoa física)

Representatives

Mary Margaret L. O'Donnell Blue Filament Law PLLC

Technical classification

Nice Classes

Class 5Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticalsexcept food or nutritional supplements and dietetic preparationspharmaceutical preparations for the treatment and prevention of rare metabolicneurologicalhematologicalgenetic and skin diseasestumorscanceranaphylaxiswoundsfertility issues and disorderspharmaceutical preparations for tissues and organ preservation and graft transplantation; Sanitary products for medicinesanitary preparations for medical purposes; Medicinal bathsmedicated mineral salts for bathsbath herbs for medical purposes; Capsules sold empty for medicines; Stem cells for medical use; Diagnostic reagents and contrast agents for medical use; Chemical preparations for medical usefor use in cell cultures for medical purposes and for the treatment and prevention of rare metabolicneurologicalhematologicalgenetic and skin diseasestumorscanceranaphylaxiswoundsfertility issues and disorderspharmaceutical preparations for tissues and organ preservation and graft transplantation; Biological preparations for medical usefor use in cell cultures for medical purposes and for the treatment and prevention of rare metabolicneurologicalhematologicalgenetic and skin diseasestumorscanceranaphylaxiswoundsfertility issues and disorderspharmaceutical preparations for tissues and organ preservation and graft transplantation; Bacteriological preparations for medical use; Surgical and medical plasters; Materials for dressingsgauze for dressingsbandages for dressingsmedical and surgical dressingssterilized dressings

Class 35

Wholesale store services and retail store services featuring pharmaceutical productsexcept for food or nutritional supplements and dietetic preparationsveterinary productssanitary products for medical purposessurgicalmedicaldental and veterinary apparatus and instruments as well as medical supplies; demonstrating products in the medical sector

Publications

History of USPTO decisions and trademark events.

37 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/18/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/03/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/15/2025

FIMP

FINAL DISPOSITION PROCESSED

04/15/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/19/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/17/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/01/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/01/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/19/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/19/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/03/2024

PUBO

PUBLISHED FOR OPPOSITION

09/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/14/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/26/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

07/26/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/26/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

07/26/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/26/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/22/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/22/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/22/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/01/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/01/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/01/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/01/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/01/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/01/2024

RFNT

REFUSAL PROCESSED BY IB

04/02/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/13/2024

RFRR

REFUSAL PROCESSED BY MPU

03/13/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/13/2024

CNRT

NON-FINAL ACTION WRITTEN

02/12/2024

DOCK

ASSIGNED TO EXAMINER

02/09/2024

MAFR

APPLICATION FILING RECEIPT MAILED

09/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/28/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

08/16/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/04/2023

Continuous trademark protection

Get notified about every new filing that threatens THERAVIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.